Cac3319 Inactivation Sustains Solventogenesis Through Proteomic and Phosphoregulatory Remodeling in Clostridium acetobutylicum
Biotechnology and Bioengineering · 29.10.2026
DOI: 10.1002/bit.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 29.10.2026. Verfasst von Xutong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, China. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Liaoning Young Elite Scientists Sponsorship Program.
Abstract (Originalsprache)
Clostridium acetobutylicum is a promising biofuel producer for acetone‐butanol‐ethanol (ABE) fermentation, yet sustained butanol production is constrained by the short duration of solventogenic activity. Although the orphan histidine kinase Cac3319 has been implicated in Spo0A phosphorylation, sporulation, and solvent production, metabolic and phosphorylation changes following cac3319 inactivation have not been systematically characterized. Here, we integrated fermentation kinetics, comparative proteomics, and Ti 4+ ‐IMAC phosphoproteomics to investigate the effects of cac3319 inactivation in C. acetobutylicum ATCC 55025. The cac3319 knockout prolonged late‐stage metabolic activity without impairing early growth, enabling continued glucose utilization and solvent accumulation after entry into solventogenesis. Final butanol and total ABE titers increased from 13.0 to 17.5 g L −1 and from 18.5 to 28.5 g L −1 , respectively. Proteomic analysis revealed increased protein abundance spanning central carbon metabolism, acid reassimilation, energy metabolism, and protein protection. Phosphoproteomic analysis further revealed phase‐dependent remodeling of detectable phosphorylation events, indicating that post‐translational regulation was reshaped during the acidogenic‐to‐solventogenic transition. These coordinated changes supported a metabolically active and stress‐tolerant state conducive to sustained solventogenesis. Collectively, these findings provide new insights into histidine kinase‐mediated regulation of clostridial solventogenesis and highlight cac3319 inactivation as a promising strategy for sustaining late‐stage metabolic activity and improving butanol production in ABE fermentation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, China.
- State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences,…
- Liaoning Dalian Ecological Environment Monitoring Center, Dalian, China.
ORCID-Profile: Liting Lyu, Chuang Xue
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Liaoning Young Elite Scientists Sponsorship Program
- Liaoning Provincial Science and Technology Plan Joint Program
Zitieren
APA
Liu, X., Lyu, L., Zhu, C., Zhang, M., Wu, Y., Ye, M., Zheng, L., Dong, M., & Xue, C. (2026). Cac3319 Inactivation Sustains Solventogenesis Through Proteomic and Phosphoregulatory Remodeling in Clostridium acetobutylicum. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70436
Vancouver
Liu X, Lyu L, Zhu C, Zhang M, Wu Y, Ye M, et al. Cac3319 Inactivation Sustains Solventogenesis Through Proteomic and Phosphoregulatory Remodeling in Clostridium acetobutylicum. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70436
BibTeX
@article{Liu2026,
author = {Liu, Xutong and Lyu, Liting and Zhu, Chao and Zhang, Meng and Wu, Youduo and Ye, Mingliang and Zheng, Lin and Dong, Mingming and Xue, Chuang},
title = {Cac3319 Inactivation Sustains Solventogenesis Through Proteomic and Phosphoregulatory Remodeling in Clostridium acetobutylicum},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70436}
}
EUVIMED